Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 238,361 | 227,891 | 273,710 | 295,278 | 463,156 |
| Receivables | 837,275 | 704,909 | 575,950 | 614,292 | 474,643 |
| Inventories | 822,250 | 998,012 | 743,910 | 457,033 | 416,915 |
| TOTAL | $2,357,719 | $2,367,830 | $1,931,478 | $1,574,757 | $1,523,459 |
| Non-Current Assets | |||||
| PPE Net | 548,025 | 537,856 | 498,181 | 463,490 | 417,335 |
| Intangibles | 3,327,959 | 3,322,640 | 2,282,386 | 2,320,483 | 2,338,492 |
| Other Non-Current Assets | 638,691 | 523,382 | 383,808 | 369,395 | 308,090 |
| TOTAL | $4,514,675 | $4,383,878 | $3,164,375 | $3,153,368 | $3,063,917 |
| Total Assets | $6,872,394 | $6,751,708 | $5,095,853 | $4,728,125 | $4,587,376 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 237,728 | 150,756 | 159,245 | 138,008 | 135,786 |
| Accrued Expenses | 377,678 | 365,660 | 344,722 | 320,599 | 270,353 |
| TOTAL | $910,655 | $758,533 | $689,299 | $911,766 | $602,761 |
| Non-Current Liabilities | |||||
| Long Term Debt | 697,313 | 1,431,234 | 765,325 | 643,351 | 1,164,133 |
| Deferred Revenues | 152,554 | 138,072 | 108,667 | 109,611 | 98,617 |
| Other Non-Current Liabilities | 183,701 | 222,202 | 175,309 | 184,514 | 223,137 |
| TOTAL | $1,097,696 | $1,863,272 | $1,045,803 | $930,680 | $1,487,588 |
| Total Liabilities | $2,008,351 | $2,621,805 | $1,735,102 | $1,842,446 | $2,090,349 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,932 | 147,071 | 146,425 | 145,681 | 144,901 |
| Common Shares | 588 | 588 | 586 | 583 | 580 |
| Retained earnings | 4,991,647 | 4,253,016 | 3,613,736 | 3,079,640 | 2,832,991 |
| Other shareholders' equity | -251,796 | -272,784 | -313,003 | -193,743 | -284,238 |
| TOTAL | $4,864,043 | $4,129,903 | $3,360,751 | $2,885,679 | $2,497,027 |
| Total Liabilities And Equity | $6,872,394 | $6,751,708 | $5,095,853 | $4,728,125 | $4,587,376 |